Stock info Catalent Inc. | Filter  Basic-Info

Catalent Inc.

The past year was a relatively good year for Catalent Inc. investors

Over the period from December 2015 till December 2016 the stock gained around 4 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 0 percent. Catalent Inc.'s revenues between 2011 and 2015 were relatively stable and moved between 1,69 billion dollars and 1,83 billion dollars. The net results between 2011 and 2015 were far from constant and fluctuated between -29,1 million dollars and 210,2 million dollars.

Catalent Inc. is active in the biotech sector. The period from 2006 till the end of 2016 the international sector gained around 59 percent. As from 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.

Over the past 5 years the American company paid out dividends.

Catalent Inc.' balance mostly financed with equity

At the end of 2015 the biotech company's balance sheet was worth 3,15 billion dollars. At the end of 2015 the total debt positon equaled 2,51 billion dollars. This is around 79,84 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around 17. So investors paid 17 times the company's 2015's EPS. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the biotech company's market capitalization (the number of shares times the market price) equaled around 2,99 billion dollars. At the end of 2015 the American company had around 121,35 million stocks listed on the exchanges.

At this page you find all Catalent Inc.'s financial reports. More information about Catalent Inc. can be found it's website. .